ACC/AHA与ESC/EACT对膜心脏病的指导方针:EJPC指导方针对比审查
Maciej Debski1,2, Vasiliki Tsampasian1,2, Joseph Zacharias3
1Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, United Kingdom.
European journal of preventive cardiology
|January 12, 2026
概括
通过比较2025年欧洲和美国对膜心脏病的指导方针,可以发现干预时间和透导管治疗的关键差异. 这些更新指导临床决策和未来的研究重点.
科学领域:
- 心脏病学 心脏病学
- 临床决策 - 临床决策
- 医学指导方针 医学指导方针
背景情况:
- 膜心脏病的管理面临着持续的临床挑战.
- 美国心脏病学会/美国心脏协会 (ACC/AHA) 和欧洲心脏病学会/欧洲心胸外科协会 (ESC/EACTS) 的国际指南提供了治疗框架.
- 最近的2025年更新突出了不断变化的实践.
研究的目的:
- 为了比较最新的国际心脏膜疾病管理指南.
- 确定ACC/AHA和ESC/EACTS指南之间的一致性和差异.
- 为了突出未来研究膜心脏病的领域.
主要方法:
- 对2025年ACC/AHA和ESC/EACTS指南进行比较分析.
- 在欧洲指南中纳入的新试验证据的审查.
- 确定建议中的关键差异.
主要成果:
- 在干预原则,假肢选择和心脏队伍的作用方面存在广泛的共识.
- 在主动脉狭窄和吐的早期干预门中发现了显著的差异.
- 扩大了跨导管边缘到边缘修复, mitra 置换和三管修复/跨导管治疗的建议.
- 突出了穿透导管大动脉植入的冠状动脉评估的发展策略和性别特定的考虑.
结论:
- 2025年ESC/EACTS指南包含了大量新的试验证据,导致与ACC/AHA建议的关键分歧.
- 在干预时间,透导管治疗指示和特定的程序方法方面存在差异.
- 未来的研究应该解决这些差异以及心脏膜疾病管理的不断变化的方面.
相关概念视频
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...


